Comera Life Sciences Holdings, Inc.
Symbool: CMRA
NASDAQ
0.02684
USDMarktprijs vandaag
-0.0074
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
0.83M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Comera Life Sciences Holdings, Inc. (CMRA) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.4 | 6.5 | 0.2 | |||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.net-receivables | 0 | 0 | 0.2 | 0.1 | |||
balance-sheet.row.inventory | 0 | 2.5 | 0 | 0 | |||
balance-sheet.row.other-current-assets | 0 | 0.1 | 0 | 0 | |||
balance-sheet.row.total-current-assets | 0 | 3.1 | 6.8 | 0.3 | |||
balance-sheet.row.property-plant-equipment-net | 0 | 0.6 | 0.6 | 0.2 | |||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.other-non-current-assets | 0 | 0.1 | 0.1 | 0.1 | |||
balance-sheet.row.total-non-current-assets | 0 | 0.7 | 0.6 | 0.2 | |||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-assets | 0 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.account-payables | 0 | 1.5 | 0.4 | 0.1 | |||
balance-sheet.row.short-term-debt | 0 | 0.7 | 0.1 | 0.1 | |||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-debt-total | 0 | 0.1 | 0.2 | 0.2 | |||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||
balance-sheet.row.other-current-liab | 0 | 2.8 | 0 | 0 | |||
balance-sheet.row.total-non-current-liabilities | 0 | 4.9 | 21.1 | 0.2 | |||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 0.3 | 0 | |||
balance-sheet.row.total-liab | 0 | 10 | 22.1 | 0.4 | |||
balance-sheet.row.preferred-stock | 0 | 4517.7 | 20.9 | 0 | |||
balance-sheet.row.common-stock | 0 | 0 | 0 | 10.7 | |||
balance-sheet.row.retained-earnings | 0 | -34.9 | -16.9 | -11.4 | |||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -20.9 | 0 | |||
balance-sheet.row.other-total-stockholders-equity | 0 | -4489.1 | 2.2 | 0.9 | |||
balance-sheet.row.total-stockholders-equity | 0 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-equity | 0 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||
Total Investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-debt | 0 | 0.8 | 0.3 | 0.2 | |||
balance-sheet.row.net-debt | 0 | 0.3 | -6.2 | 0 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -18 | -5.5 | -2.1 | |||
cash-flows.row.depreciation-and-amortization | 0 | 0.1 | 0.1 | 0.1 | |||
cash-flows.row.deferred-income-tax | 0 | 0 | -0.2 | 0 | |||
cash-flows.row.stock-based-compensation | 0 | 0.4 | 1.1 | 0.1 | |||
cash-flows.row.change-in-working-capital | 0 | 2.6 | 0.6 | 0 | |||
cash-flows.row.account-receivables | 0 | 0 | 0.1 | -0.1 | |||
cash-flows.row.inventory | 0 | 0 | 0.2 | 0.1 | |||
cash-flows.row.account-payables | 0 | 0.9 | 0.3 | 0 | |||
cash-flows.row.other-working-capital | 0 | 1.7 | 0 | 0 | |||
cash-flows.row.other-non-cash-items | 0 | 5.2 | 0.1 | 0.2 | |||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||
cash-flows.row.common-stock-issued | 0 | 0.8 | 0 | 1.4 | |||
cash-flows.row.common-stock-repurchased | 0 | 650 | 0 | 0 | |||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-financing-activites | 0 | -645.6 | 10.3 | 0.2 | |||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 5.2 | 10.3 | 1.6 | |||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||
cash-flows.row.net-change-in-cash | 0 | -4.6 | 6.4 | -0.3 | |||
cash-flows.row.cash-at-end-of-period | 0 | 2 | 6.6 | 0.2 | |||
cash-flows.row.cash-at-beginning-of-period | 0 | 6.6 | 0.2 | 0.4 | |||
cash-flows.row.operating-cash-flow | 0 | -9.8 | -3.8 | -1.8 | |||
cash-flows.row.capital-expenditure | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.free-cash-flow | 0 | -9.8 | -3.9 | -1.8 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0.6 | 0.3 | 0.4 | |||
income-statement-row.row.cost-of-revenue | 0 | 0.2 | 0.2 | 0.1 | |||
income-statement-row.row.gross-profit | 0 | 0.4 | 0.2 | 0.3 | |||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||
income-statement-row.row.research-development | 0 | - | - | - | |||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.other-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.operating-expenses | 0 | 12.4 | 5.7 | 2.5 | |||
income-statement-row.row.cost-and-expenses | 0 | 12.6 | 5.9 | 2.6 | |||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.total-other-income-expensenet | 0 | -6 | 0.1 | 0 | |||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||
income-statement-row.row.other-operating-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.total-operating-expenses | 0 | -6 | 0.1 | 0 | |||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | |||
income-statement-row.row.depreciation-and-amortization | 0 | -1.4 | -0.1 | 0.1 | |||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||
income-statement-row.row.operating-income | 0 | -12 | -5.5 | -2.1 | |||
income-statement-row.row.income-before-tax | 0 | -18 | -5.5 | -2.1 | |||
income-statement-row.row.income-tax-expense | 0 | 6 | -0.2 | 0 | |||
income-statement-row.row.net-income | 0 | -24 | -5.3 | -2.1 |
Vaak gestelde vragen
Wat is Comera Life Sciences Holdings, Inc. (CMRA) totale activa?
Comera Life Sciences Holdings, Inc. (CMRA) totale activa is 3727113.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.735.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -84.219.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -9.143.
Wat is Comera Life Sciences Holdings, Inc. (CMRA) nettowinst (netto-inkomen)?
De nettowinst is -24038181.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 775048.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 12392727.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.